Ep. 322 - Takeaways from BioCentury Grand Rounds Europe

Is this the U.K.’s moment to capitalize on its biotech ecosystem? That was one of the primary themes discussed at the debut Grand Rounds — Europe conference last week in Cambridge, U.K. BioMarin"s James Sabry and Astex"s Michelle Jones joined BioCentury’s analysts on a special edition of the BioCentury This Week podcast recorded live at the event to discuss their key takeaways from the two-day conference. Beyond the state of the U.K. biopharma ecosystem, the analysts discussed the meeting’s major science themes, including what’s next for DNA damage repair pathway targets, both inside and outside of cancer; whether obesity should be recast as a brain disease; and the cutting edge of small molecule design. View full story: https://www.biocentury.com/article/657082 #UKBiotech #TranslationalMedicine #DrugPricing #GlobalCollaboration #Aging #Biologics #SmallMolecules #Biobanking 00:00 - Introduction 00:35 - Key Takeaways 02:14 - The State of the U.K. Biotech Ecosystem 09:01 - Scientific Highlights & Panel Takeaways 22:44 - Closing Remarks and Future Events To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com. Reach us by sending a text